ETP Nanomedicine and NANOMED2020: Towards a New Nanomedicine Horizon Olivier Fontaine, Nanobiotix, speaking at Nanomedicine 2014.
Challenges of Implementing and Validating CTC Assays in Oncology Clinical Trials Iman Jilani, Pfizer, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Biomarker Development to Improve Trials for Type 1 Diabetes Professor Matthias von Herrath, The La Jolla Institute for Allergy and Immunology, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Companion Diagnostics Development at the Siemens Clinical Laboratory Sunil Pandit, Siemens Healthcare Diagnostics, speaking at Exosomes and Circulating Biomarkers 2013.
Esoteric Diagnostics in China: A Case Review of Building up the First and Largest Esoteric Laboratory Network in China Shiang Huang, Kindstar Global, speaking at Point-of-Care Diagnostics World Congress 2013.
Companies in Translation with CIRM Dr Alan Trounson, California Institute for Regenerative Medicine, speaking at Stem Cells 2012
Drug Discovery Outsourcing: the Importance of Integration in the Selection of Higher Quality Clinical Candidates Simone Braggio, Director, Head of Drug Metabolism & Pharmacokinetics, Aptuit speaking at Pharma Outsourcing Congress 2011
RNA-Seq for High Throughput Clinical Studies Wenzhong Xiao, Assistant Professor of Bioinformatics, Massachusetts General Hospital, speaking at Next-Gen Sequencing Congress 2011.
Preclinical Drug Safety: High Quality Data obtained with a New Automated Patch Clamp Platform Olaf Scheel, CSO, Cytocentrics AG speaking at Pharma Outsourcing Congress 2011